BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guitton J, Buronfosse T, Desage M, Flinois JP, Perdrix JP, Brazier JL, Beaune P. Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth. 1998;80:788-795. [PMID: 9771309 DOI: 10.1093/bja/80.6.788] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Campos SP, de Lurdes Pinto M, Gomes G, de Pinho PG, Monteiro JA, Félix LM, Branco PS, Ferreira LM, Antunes LM. Expression of CYP1A1 and CYP1A2 in the liver and kidney of rabbits after prolonged infusion of propofol. Experimental and Toxicologic Pathology 2016;68:521-31. [DOI: 10.1016/j.etp.2016.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Gardiner SJ, Begg EJ. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev 2006;58:521-90. [PMID: 16968950 DOI: 10.1124/pr.58.3.6] [Cited by in Crossref: 258] [Cited by in F6Publishing: 191] [Article Influence: 17.2] [Reference Citation Analysis]
3 Gill KL, Gertz M, Houston JB, Galetin A. Application of a physiologically based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation: utility of in vitro and in vivo data. Drug Metab Dispos 2013;41:744-53. [PMID: 23303442 DOI: 10.1124/dmd.112.050294] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
4 Félix LM, Correia F, Pinto PA, Campos SP, Fernandes T, Videira R, Oliveira M, Peixoto FP, Antunes LM. Propofol affinity to mitochondrial membranes does not alter mitochondrial function. European Journal of Pharmacology 2017;803:48-56. [DOI: 10.1016/j.ejphar.2017.03.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sandra L, Smits A, Allegaert K, Nicolaï J, Annaert P, Bouillon T. Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation. Br J Clin Pharmacol 2021;87:2089-97. [PMID: 33085795 DOI: 10.1111/bcp.14620] [Reference Citation Analysis]
6 Campos S, Monteiro J, Valenzuela B, Gonçalinho H, de Pinho PG, Fresco P, Félix L, Antunes L. Evidence of Different Propofol Pharmacokinetics under Short and Prolonged Infusion Times in Rabbits. Basic Clin Pharmacol Toxicol 2016;118:421-31. [PMID: 26551921 DOI: 10.1111/bcpt.12521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Hamaoka N, Oda Y, Hase I, Asada A. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies. British Journal of Anaesthesia 2001;86:540-4. [DOI: 10.1093/bja/86.4.540] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
8 Helfenbein J, Lartigue C, Noirault E, Azim E, Legailliard J, Galmier MJ, Madelmont JC. Isotopic Effect Study of Propofol Deuteration on the Metabolism, Activity, and Toxicity of the Anesthetic. J Med Chem 2002;45:5806-8. [DOI: 10.1021/jm020864q] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
9 Stanford SC, Stanford BJ. Reply to J. L. Palmer — Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine? J Psychopharmacol 2000;14:186-7. [DOI: 10.1177/026988110001400210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003; 9(9): 1959-1962 [PMID: 12970884 DOI: 10.3748/wjg.v9.i9.1959] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
11 Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 2002;34:83-448. [DOI: 10.1081/dmr-120001392] [Cited by in Crossref: 558] [Cited by in F6Publishing: 143] [Article Influence: 29.4] [Reference Citation Analysis]
12 Bleeker C, Vree T, Lagerwerf A, Willems-van Bree E. Recovery and long-term renal excretion of propofol, its glucuronide, and two di-isopropylquinol glucuronides after propofol infusion during surgery. British Journal of Anaesthesia 2008;101:207-12. [DOI: 10.1093/bja/aen134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
13 Moody DE. Drug Interactions with Benzodiazepines: Epidemiologic Correlates with Other CNS Depressants and In Vitro Correlates with Inhibitors and Inducers of Cytochrome P450 3A4. In: Mozayani A, Raymon L, editors. Handbook of Drug Interactions. Totowa: Humana Press; 2012. pp. 25-116. [DOI: 10.1007/978-1-61779-222-9_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Chan W, Chen T, Chen R, Sun W, Ueng T. Propofol metabolism is enhanced after repetitive ketamine administration in rats: the role of cytochrome P-450 2B induction. British Journal of Anaesthesia 2006;97:351-8. [DOI: 10.1093/bja/ael173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
15 Hsiao Y, Petersson C, Svensson MA, Norinder U. A Pragmatic Approach Using First-Principle Methods to Address Site of Metabolism with Implications for Reactive Metabolite Formation. J Chem Inf Model 2012;52:686-95. [DOI: 10.1021/ci200523f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
16 Backman JT, Filppula AM, Niemi M, Neuvonen PJ. Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacol Rev. 2016;68:168-241. [PMID: 26721703 DOI: 10.1124/pr.115.011411] [Cited by in Crossref: 103] [Cited by in F6Publishing: 88] [Article Influence: 20.6] [Reference Citation Analysis]
17 Kanazawa H, Okada A, Igarashi E, Higaki M, Miyabe T, Sano T, Nishimura R. Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography–mass spectrometry. Journal of Chromatography A 2004;1031:213-8. [DOI: 10.1016/j.chroma.2003.12.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
18 Zhou SF, Zhou ZW, Huang M. Polymorphisms of human cytochrome P450 2C9 and the functional relevance. Toxicology 2010;278:165-88. [PMID: 19715737 DOI: 10.1016/j.tox.2009.08.013] [Cited by in Crossref: 78] [Cited by in F6Publishing: 61] [Article Influence: 6.5] [Reference Citation Analysis]
19 Zhou SF, Wang B, Yang LP, Liu JP. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 2010;42:268-354. [PMID: 19961320 DOI: 10.3109/03602530903286476] [Cited by in Crossref: 158] [Cited by in F6Publishing: 141] [Article Influence: 14.4] [Reference Citation Analysis]
20 Tajima T, Hirakawa K, Kawaguchi H, Sakamoto A. Proton nuclear magnetic resonance and pattern recognition analysis of liver extracts from rats under different anesthetics. BMC Med Imaging 2012;12:28. [PMID: 22898647 DOI: 10.1186/1471-2342-12-28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Kim H, Kim K, Ku H, Park S, Choi H, Moon J, Park B, Kim J, Yea SS, Lee C, Lee HS, Shin J, Liu K. Identification and Characterization of Potent CYP2B6 Inhibitors in Woohwangcheongsimwon Suspension, an Herbal Preparation Used in the Treatment and Prevention of Apoplexy in Korea and China. Drug Metab Dispos 2008;36:1010-5. [DOI: 10.1124/dmd.107.019612] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
22 Ouchi K. Intravenous General Anesthesia for Patients with Neurological Disorders. Glob J Anesth 2014. [DOI: 10.17352/2455-3476.000018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Rydberg P, Vasanthanathan P, Oostenbrink C, Olsen L. Fast prediction of cytochrome P450 mediated drug metabolism. ChemMedChem 2009;4:2070-9. [PMID: 19852016 DOI: 10.1002/cmdc.200900363] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
24 Tanaka E, Takano Y, Inomata S, Toyooka H, Honda K. Premedication medicines do not cause drug metabolic interaction with propofol using human liver microsomes in vitro. Eur J Clin Pharmacol 2004;60:565-8. [PMID: 15351923 DOI: 10.1007/s00228-004-0807-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
25 Mikstacki A, Skrzypczak-Zielinska M, Tamowicz B, Zakerska-Banaszak O, Szalata M, Slomski R. The impact of genetic factors on response to anaesthetics. Adv Med Sci 2013;58:9-14. [PMID: 23640947 DOI: 10.2478/v10039-012-0065-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
26 Murayama N, Minoshima M, Shimizu M, Guengerich FP, Yamazaki H. Involvement of human cytochrome P450 2B6 in the ω - and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica 2008;37:717-24. [DOI: 10.1080/00498250701449431] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
27 Chi X, Pan J, Cai J, Luo G, Li S, Yuan D, Rui J, Chen W, Hei Z. Pharmacokinetic Analysis of Propofol Target-Controlled Infusion Models in Chinese Patients with Hepatic Insufficiency. Med Sci Monit 2018;24:6925-33. [PMID: 30269150 DOI: 10.12659/MSM.910103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
28 Niu RJ, Zheng QC, Zhang JL, Zhang HX. Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods. J Mol Model 2011;17:2839-46. [PMID: 21301907 DOI: 10.1007/s00894-011-0970-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
29 Michelet R, Van Bocxlaer J, Allegaert K, Vermeulen A. The use of PBPK modeling across the pediatric age range using propofol as a case. J Pharmacokinet Pharmacodyn 2018;45:765-85. [PMID: 30298439 DOI: 10.1007/s10928-018-9607-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
30 Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41:89-295. [PMID: 19514967 DOI: 10.1080/03602530902843483] [Cited by in Crossref: 475] [Cited by in F6Publishing: 401] [Article Influence: 39.6] [Reference Citation Analysis]
31 Moody DE. Drug Interactions with Benzodiazepines. In: Mozayani A, Raymon LP, editors. Handbook of Drug Interactions. Totowa: Humana Press; 2004. pp. 3-88. [DOI: 10.1007/978-1-59259-654-6_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Kim J, In S, Park Y, Park M, Kim E, Lee S. Quantitative analysis of propofol-glucuronide in hair as a marker for propofol abuse. Anal Bioanal Chem 2013;405:6807-14. [DOI: 10.1007/s00216-013-7105-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
33 Li Lin A, Shangari N, Chan TS, Remirez D, O'brien PJ. Herbal monoterpene alcohols inhibit propofol metabolism and prolong anesthesia time. Life Sciences 2006;79:21-9. [DOI: 10.1016/j.lfs.2005.12.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
34 Yamazaki H, Shimizu M, Nagashima T, Minoshima M, Murayama N. Rat Cytochrome P450 2C11 in Liver Microsomes Involved in Oxidation of Anesthetic Agent Propofol and Deactivated by Prior Treatment with Propofol. Drug Metab Dispos 2006;34:1803-5. [DOI: 10.1124/dmd.106.011627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
35 Favetta P, Degoute CS, Perdrix JP, Dufresne C, Boulieu R, Guitton J. Propofol metabolites in man following propofol induction and maintenance. Br J Anaesth 2002;88:653-8. [PMID: 12067002 DOI: 10.1093/bja/88.5.653] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
36 Rua F, Di Nardo G, Sadeghi SJ, Gilardi G. Toward reduction in animal sacrifice for drugs: molecular modeling of Macaca fascicularis P450 2C20 for virtual screening of Homo sapiens P450 2C8 substrates. Biotechnol Appl Biochem 2012;59:479-89. [PMID: 23586958 DOI: 10.1002/bab.1051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
37 Ho C, Hayes D Jr, Khosravi M, Splaingard ML, Tumin D, Lloyd EA. Sedation with Propofol for Bronchoscopy in Cystic Fibrosis Lung Transplant Recipients. Lung 2018;196:435-9. [PMID: 29797070 DOI: 10.1007/s00408-018-0119-5] [Reference Citation Analysis]
38 Dinis-Oliveira RJ. Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects. Biomed Res Int 2018;2018:6852857. [PMID: 29992157 DOI: 10.1155/2018/6852857] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
39 Kneiseler G, Bachmann HS, Bechmann LP, Dechene A, Heyer T, Baba H, Saner F, Jochum C, Gerken G, Canbay A. A Rare Case of Propofol-Induced Acute Liver Failure and Literature Review. Case Rep Gastroenterol 2010;4:57-65. [PMID: 21103229 DOI: 10.1159/000262448] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
40 Krause TK, Jansen L, Scholz J, Böttcher H, Wappler F, Burmeister M, Esch JSA. Propofol anesthesia in children does not induce sister chromatid exchanges in lymphocytes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2003;542:59-64. [DOI: 10.1016/j.mrgentox.2003.08.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
41 Rison RA, Ko DY. Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. Clinical Neurology and Neurosurgery 2009;111:558-61. [DOI: 10.1016/j.clineuro.2009.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Allegaert K, Peeters M, Verbesselt R, Tibboel D, Naulaers G, de Hoon J, Knibbe C. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. British Journal of Anaesthesia 2007;99:864-70. [DOI: 10.1093/bja/aem294] [Cited by in Crossref: 105] [Cited by in F6Publishing: 75] [Article Influence: 7.5] [Reference Citation Analysis]
43 Ouchi K, Sugiyama K. Required propofol dose for anesthesia and time to emerge are affected by the use of antiepileptics: prospective cohort study. BMC Anesthesiol 2015;15:34. [PMID: 25788855 DOI: 10.1186/s12871-015-0006-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
44 Loryan I, Lindqvist M, Johansson I, Hiratsuka M, van der Heiden I, van Schaik RH, Jakobsson J, Ingelman-sundberg M. Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia. Eur J Clin Pharmacol 2012;68:397-406. [DOI: 10.1007/s00228-011-1132-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
45 Zhai X, Shu Z, Zhang S, Chen D, Lu Y. Pharmacokinetic and Pharmacodynamic Interactions of Ethanol and Propofol in Rabbits. Chroma 2010;72:981-5. [DOI: 10.1365/s10337-010-1757-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Lichtenbelt B, Mertens M, Vuyk J. Strategies to Optimise Propofol-Opioid Anaesthesia: . Clinical Pharmacokinetics 2004;43:577-93. [DOI: 10.2165/00003088-200443090-00002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
47 Tomioka S, Nakajo N. No genotoxic effect of propofol in Chinese hamster ovary cells: Analysis by sister chromatid exchanges: No genotoxic effect of propofol. Acta Anaesthesiologica Scandinavica 2000;44:1261-5. [DOI: 10.1034/j.1399-6576.2000.441013.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
48 Iohom G, Ni Chonghaile M, Oʼbrien JK, Cunningham AJ, Fitzgerald DF, Shields DC. An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia: . European Journal of Anaesthesiology 2007;24:912-9. [DOI: 10.1017/s0265021507000476] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
49 Allegaert K, Hoon JD, Verbesselt R, Naulaers G, Murat I. Maturational pharmacokinetics of single intravenous bolus of propofol: MATURATIONAL PHARMACOKINETICS OF PROPOFOL. Pediatric Anesthesia 2007;17:1028-34. [DOI: 10.1111/j.1460-9592.2007.02285.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
50 Tai YT, Lin YL, Chang CC, Cherng YG, Don MJ, Chen RM. Ring-oxidative biotransformation and drug interactions of propofol in the livers of rats. Biomed Res Int 2015;2015:658928. [PMID: 25710017 DOI: 10.1155/2015/658928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
51 Oda Y, Hamaoka N, Hiroi T, Imaoka S, Hase I, Tanaka K, Funae Y, Ishizaki T, Asada A. Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. Br J Clin Pharmacol. 2001;51:281-285. [PMID: 11298076 DOI: 10.1046/j.1365-2125.2001.00344.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 3.8] [Reference Citation Analysis]
52 Seo K, Kim H, Ku H, Ahn H, Park S, Bae SK, Shin J, Liu K. The monoterpenoids citral and geraniol are moderate inhibitors of CYP2B6 hydroxylase activity. Chemico-Biological Interactions 2008;174:141-6. [DOI: 10.1016/j.cbi.2008.06.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
53 Xu H, Chen M, Yu F, Zhang T, Wu B. Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice. Drug Metab Dispos 2020;48:681-9. [PMID: 32527940 DOI: 10.1124/dmd.120.000030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Karda R, Perocheau DP, Suff N, Ng J, Delhove JMKM, Buckley SMK, Richards S, Counsell JR, Hagberg H, Johnson MR, McKay TR, Waddington SN. Continual conscious bioluminescent imaging in freely moving somatotransgenic mice. Sci Rep 2017;7:6374. [PMID: 28743959 DOI: 10.1038/s41598-017-06696-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]